Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.
Jérôme LeGoff;
Gérard Grésenguet;
Chrysostome Gody;
Jean De Dieu Longo;
Nzambi Khonde;
Helen A Weiss 
;
Philippe Mayaud ;
Laurent Bélec;
ANRS 12-12 Study Group;
(2011)
Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.
Clinical and vaccine immunology, 18 (7).
pp. 1191-1193.
ISSN 1556-6811
DOI: 10.1128/CVI.05003-11
;
Philippe Mayaud ;
Laurent Bélec;
ANRS 12-12 Study Group;
(2011)
Performance of the BioPlex 2200 multiplexing immunoassay platform for the detection of herpes simplex virus type 2 specific antibodies in African settings.
Clinical and vaccine immunology, 18 (7).
pp. 1191-1193.
ISSN 1556-6811
DOI: 10.1128/CVI.05003-11
The BioPlex platform was evaluated for the detection of herpes simplex virus 2 (HSV-2) antibodies in sub-Saharan Africa individuals in comparison to clinicovirological standards and compared to HerpeSelect. The sensitivities and specificities were, respectively, 88.9% and 93.5% for BioPlex and 89.9% and 92.7% for HerpeSelect. The agreement between both assays was 95.7%.
Full text not available from this repository.
Downloads